Inhibition of mitochondrial carrier homolog 2 (MTCH2) suppresses tumor invasion and enhances sensitivity to temozolomide in malignant glioma
Abstract Background Malignant glioma exerts a metabolic shift from oxidative phosphorylation (OXPHOs) to aerobic glycolysis, with suppressed mitochondrial functions. This phenomenon offers a proliferation advantage to tumor cells and decrease mitochondria-dependent cell death. However, the underlyin...
Saved in:
Main Authors: | Qiuyun Yuan (Author), Wanchun Yang (Author), Shuxin Zhang (Author), Tengfei Li (Author), Mingrong Zuo (Author), Xingwang Zhou (Author), Junhong Li (Author), Mao Li (Author), Xiaoqiang Xia (Author), Mina Chen (Author), Yanhui Liu (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2021-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
MEOX2 promotes glioma growth and temozolomide chemoresistance
by: Tengfei Li, et al.
Published: (2024) -
Prognostic value of cuproptosis-related genes signature and its impact on the reshaped immune microenvironment of glioma
by: Siliang Chen, et al.
Published: (2022) -
Purine metabolism-related gene expression signature predicts survival outcome and indicates immune microenvironment profile of gliomas
by: Siliang Chen, et al.
Published: (2022) -
MTCH2 in Metabolic Diseases, Neurodegenerative Diseases, Cancers, Embryonic Development and Reproduction
by: Peng X, et al.
Published: (2024) -
Prognosis prediction and tumor immune microenvironment characterization based on tryptophan metabolism-related genes signature in brain glioma
by: Shuxin Zhang, et al.
Published: (2022)